Home/Filings/4/0001493152-23-022668
4//SEC Filing

Arno Andrew 4

Accession 0001493152-23-022668

CIK 0001642380other

Filed

Jun 26, 8:00 PM ET

Accepted

Jun 27, 9:30 PM ET

Size

9.5 KB

Accession

0001493152-23-022668

Insider Transaction Report

Form 4
Period: 2023-06-23
Arno Andrew
Director
Transactions
  • Award

    Option to Purchase Common Stock

    2023-06-23+135,000135,000 total
    Exercise: $0.20Exp: 2033-06-23Common Stock (135,000 underlying)
  • Award

    Common Stock, no par value

    2023-06-23+30,000703,133 total
Holdings
  • Common Stock, no par value

    (indirect: See footnote)
    156,084
  • Common Stock, no par value

    (indirect: See footnote)
    156,084
Footnotes (4)
  • [F1]The Restricted Stock Units shall vest one year from the date of grant, subject to the Reporting Person's continued service as a director of the Issuer from the date of grant until the vesting date or, if earlier, until the next annual meeting of shareholders.
  • [F2]These shares of the Issuer's common stock, no par value ("Common Stock"), are held by JBA Investments LLC ("JBA"). The Reporting Person is the Manager of JBA and in such capacity has the right to vote and dispose of securities held by JBA.
  • [F3]These shares of Common Stock are held by MJA Investments LLC ("MJA"). The Reporting Person is the Manager of MJA and in such capacity has the right to vote and dispose of securities held by MJA.
  • [F4]Options shall vest one year from the date of grant, subject to the Reporting Person's continued service as a director of the Issuer from the date of grant until the vesting date or, if earlier, until the next annual meeting of shareholders.

Documents

1 file

Issuer

Oncocyte Corp

CIK 0001642380

Entity typeother

Related Parties

1
  • filerCIK 0001472122

Filing Metadata

Form type
4
Filed
Jun 26, 8:00 PM ET
Accepted
Jun 27, 9:30 PM ET
Size
9.5 KB